Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-06-23 16:34:21 ET · period of report 2026-06-22 · accession 0001636178-26-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-23 16:34 | 2026-06-22 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $146.03 | +8,750 | 27.6K | +46% | +$1.28M |
| DMT | 2026-06-23 16:34 | 2026-06-22 | UTHR | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $538.15 | -8,750 | 18.9K | -32% | -$4.71M |
| DT | 2026-06-23 16:34 | 2026-06-22 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -8,750 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | M | A | 8,750 | $146.03 | 27,626 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |
| 2 | Common | Common Stock | 2026-06-22 | S | D | 164 | $534.06 | 27,462 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $533.57 to $534.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-06-22 | S | D | 865 | $534.98 | 26,597 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $534.57 to $535.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-06-22 | S | D | 1,091 | $536.05 | 25,506 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $535.64 to $536.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-06-22 | S | D | 840 | $537.18 | 24,666 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $536.65 to $537.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-06-22 | S | D | 2,266 | $538.23 | 22,400 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $537.67 to $538.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-06-22 | S | D | 1,994 | $539.13 | 20,406 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $538.67 to $539.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-06-22 | S | D | 280 | $539.83 | 20,126 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $539.68 to $539.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-06-22 | S | D | 1,250 | $541.25 | 18,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |
| 10 | Derivative | Stock Option | 2026-06-22 | M | D | 8,750 | $0.00 | 0 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,750 Common Stock | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |